Slide 1: Q1-22 Conference Call
Q1-22 CONFERENCE CALL May 12, 2022
Slide 2: Agenda
AGENDA Introduction and safe harbor CEO – Eyal Harari, Chief Executive Officer CFO – Hadar Rahav, Chief Financial Officer Q&A
Slide 3: Safe Harbor Provision
SAFE HARBOR PROVISION Certain statements made herein that use words such as "estimate," "project," "intend," "expect," "'believe,"" may," "might," " potential," "anticipate," "plan" or similar expressions are intended to identify forward-looking statements within the meaning of the Private Securitie
Slide 4: Non-GAAP Financial Measures
NON-GAAP FINANCIAL MEASURES In this conference call, management will be referring to certain non-GAAP financial measures, which are provided to enhance the user's overall understanding of the Company’s financial performance. By excluding certain non-cash stock-based compensation expenses, non-GAAP r
Slide 5: Q1-22 Overview
Q1-22 OVERVIEW Revenues for the first quarter of 2022 were $10.6 million Cash and cash equivalents and short-term bank deposits of $70.9 million and no debt Increased 2022 revenue guidance range of $43 - $47 million 12 May, 2022 5
Slide 6: First Quarter 2022 Financial Results
FIRST QUARTER 2022 FINANCIAL RESULTS
Slide 7: Consolidated Statements of Operations (GAAP)
CONSOLIDATED STATEMENTS OF OPERATIONS (GAAP) (in thousands of U.S. dollars, except per share data) UNAUDITED Three months ended March 31, 2022 2021 Unaudited Unaudited Revenues $ 10,624 $ 9,140 Cost of revenues $ 2,837 $ 2,367 Gross profit $ 7,787 $ 6,773 Gross profit % 73% 74% Research and developm
Slide 8: Consolidated Statements of Operations (Non-GAAP)
CONSOLIDATED STATEMENTS OF OPERATIONS (NON-GAAP) (thousands of U.S. dollars, except per share data) UNAUDITED Three months ended March 31, 2022 2021 NON-GAAP (1) Revenues $ 10,624 $ 9,140 Cost of revenues $ 2,745 $ 2,323 Gross profit $ 7,879 $ 6,817 Gross profit % 74% 75% Research and development, g
Slide 9: Operating Expenses (GAAP)
OPERATING EXPENSES (GAAP) (thousands of U.S. dollars) UNAUDITED Three months ended March 31, 2022 2021 Research and development, gross $ 5,559 $ 5,104 Less - royalty-bearing participation $ 218 $ 68 Research and development, net $ 5,341 $ 5,036 Sales and marketing $ 2,905 $ 2,590 General and adminis
Slide 10: Operating Expenses (Non-GAAP)
OPERATING EXPENSES (NON-GAAP) (thousands of U.S. dollars) UNAUDITED Three months ended March 31, 2022 2021 NON-GAAP (1) Research and development, gross $ 4,948 $ 4,835 Less - royalty-bearing participation $ 218 $ 68 Research and development, net $ 4,730 $ 4,767 Sales and marketing $ 2,598 $ 2,371 Ge
Slide 11: Consolidated Balance Sheets
CONSOLIDATED BALANCE SHEETS As of (thousands of U.S. dollars) As of December 31, March 31, 2022 2021 (Unaudited) (audited) Cash and cash equivalents $ 22,357 $ 11,948 Short-term bank deposits $ 48,502 $ 58,621 Trade receivables, net $ 9,182 $ 10,031 Inventories $ 996 $ 931 Other accounts receivable
Slide 12: Current Assets vs. Current Liabilities ($M)
CURRENT ASSETS VS. CURRENT LIABILITIES ($M) 12 May, 2022 12
Slide 13: Thank You
THANK YOU All rights reserved. This presentation contains proprietary information of RADCOM Ltd. Without the express prior written permission of RADCOM Ltd., no part of the contents hereof may be used for any other purpose, disclosed to persons or firms outside the recipient company, or reproduced b